Protective effects of alcohol marginal and only in over 55s

May 09, 2001

Mortality in England and Wales attributable to current alcohol consumption 2001; 55: 383-88

The protective effects of alcohol are marginal, and mostly in men over 55 and women over 65, shows a study in the Journal of Epidemiology and Community Health.

Researchers from the London School of Hygiene and Tropical Hygiene analysed published population data on death rates and alcohol consumption for England and Wales in 1996 and 1998, respectively. The data were broken down by age and gender, and the figures used to calculate years of life lost and gained as a result of drinking alcohol.

The results showed that alcohol reduces overall death rates by around 2 per cent because it protects against coronary artery disease. But the gains were largely seen in men over the age of 55 and women over the age of 65 for whom the risk of heart disease is much higher. The protective effects of alcohol were strongest in men, with 2.8 per cent fewer deaths in men against 0.9 per cent fewer in women.

The calculations indicated that around 75 000 years of life were lost prematurely because of alcohol, and predominantly in men under the age of 44 in 1996. Road traffic accidents, suicide and alcoholic liver disease accounted for most of the deaths. In women alcohol accounted for deaths from accidental falls, breast cancer, stroke and cirrhosis of the liver.

The authors cite recent research which suggests that for alcohol consumption to be most beneficial, men should not drink until after the age of 34, while women should steer clear until they are 54. And they conclude that government estimates on the numbers of annual deaths from alcohol, published in Our Healthier Nation in 1998 are a misrepresentation of the actual figures.
-end-
Contact:

Ms Annie Britton, Department of Epidemiology and Population Health, University of London. annie@public-health.ucl.ac.uk

BMJ Specialty Journals

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.